Collegium Pharmaceutical (COLL) Return on Capital Employed (2015 - 2026)

Collegium Pharmaceutical's Return on Capital Employed history runs 12 years deep, the most recent figure standing at 15.49% for Q1 2026.

• In Q1 2026, Return on Capital Employed rose 324.0% year-over-year to 15.49%; the TTM figure through Mar 2026 stood at 15.49% (up 324.0% YoY), while the FY2025 annual figure was 14.72%, down 428.0% from the prior year.
• Return on Capital Employed was 15.49% for Q1 2026 at Collegium Pharmaceutical, up from 15.07% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 32.74% in Q2 2024 to a low of 2.28% in Q1 2022.
• Historically, Return on Capital Employed has averaged 13.18% across 5 years, with a median of 13.69% in 2025.
• The sharpest annual moves came in 2024 and 2025: Return on Capital Employed surged 2086 bps in 2024, then slumped 2143 bps in 2025.
• A 5-year view of Return on Capital Employed shows it stood at 4.42% in 2022, then surged by 438 bps to 23.77% in 2023, then tumbled by 37 bps to 14.9% in 2024, then rose by 1 bps to 15.07% in 2025, then gained by 3 bps to 15.49% in 2026.
• The last three Return on Capital Employed figures came in at 15.49% (Q1 2026), 15.07% (Q4 2025), and 13.69% (Q3 2025), per Business Quant data.